Insight into the Development of PET Radiopharmaceuticals for Oncology

While the development of positron emission tomography (PET) radiopharmaceuticals closely follows that of traditional drug development, there are several key considerations in the chemical and radiochemical synthesis, preclinical assessment, and clinical translation of PET radiotracers. As such, we o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lau, Joseph, Rousseau, Etienne, Kwon, Daniel, Lin, Kuo-Shyan, Bénard, François, Chen, Xiaoyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281377/
https://www.ncbi.nlm.nih.gov/pubmed/32455729
http://dx.doi.org/10.3390/cancers12051312

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281377/
https://www.ncbi.nlm.nih.gov/pubmed/32455729
http://dx.doi.org/10.3390/cancers12051312

Ejemplares similares